Farmakoepidemiologi – et fagfelt i stadig utvikling

Authors

  • Ingebjørg Buajordet Statens legemiddelverk
  • Helle Wallach Kildemoes Universitetet i Oslo
  • Randi Selmer Folkehelseinstituttet
  • Marit Waaseth UiT Norges arktiske universitet

DOI:

https://doi.org/10.5324/nje.v29i1-2.4038

Abstract

-

Downloads

Download data is not yet available.

Downloads

Published

2021-08-16

How to Cite

Buajordet, I. ., Kildemoes, H. W. ., Selmer , R. ., & Waaseth, M. . (2021). Farmakoepidemiologi – et fagfelt i stadig utvikling. Norsk Epidemiologi, 29(1-2). https://doi.org/10.5324/nje.v29i1-2.4038

Issue

Vol. 29 No. 1-2 (2021): Tema: Farmakoepidemiologi

Section

Articles

License

Copyright (c) 2021 Ingebjørg Buajordet, Helle Wallach Kildemoes, Randi Selmer , Marit Waaseth

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Norsk Epidemiologi licenses all content of the journal under a Creative Commons Attribution (CC-BY) licence. This means, among other things, that anyone is free to copy and distribute the content, as long as they give proper credit to the author(s) and the journal. For further information, see Creative Commons website for human readable or lawyer readable versions.

Authors who publish with this journal agree to the following terms:

1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).